Boston Scientific Files Q2 2024 10-Q
Ticker: BSX · Form: 10-Q · Filed: 2024-08-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
BSX Q2 10-Q filed. Financials and operations detailed for H1 2024.
AI Summary
Boston Scientific Corporation filed its 10-Q for the period ending June 30, 2024. The filing covers financial performance and operational details for the second quarter and the first half of 2024. Key financial data and business segments are detailed, reflecting the company's ongoing activities in the medical device sector.
Why It Matters
This filing provides investors with crucial financial and operational insights into Boston Scientific's performance, impacting investment decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate or unusual risk factors highlighted.
Key Numbers
- 20240630 — Reporting Period End Date (Indicates the end of the fiscal quarter for which the report is filed.)
- 20240801 — Filing Date (The date the 10-Q report was officially submitted to the SEC.)
Key Players & Entities
- BOSTON SCIENTIFIC CORP (company) — Filer
- 0000885725 (company) — Central Index Key
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA 01752-1234 (company) — Business Address
- 508-683-4000 (company) — Business Phone
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is June 30, 2024.
What is the company's Central Index Key (CIK)?
The company's Central Index Key (CIK) is 0000885725.
What is the business address of Boston Scientific Corp?
The business address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA 01752-1234.
What is the fiscal year end for Boston Scientific Corp?
The fiscal year end for Boston Scientific Corp is December 31.
What is the SEC file number for Boston Scientific Corp?
The SEC file number for Boston Scientific Corp is 001-11083.
From the Filing
0000885725-24-000068.txt : 20240801 0000885725-24-000068.hdr.sgml : 20240801 20240801161614 ACCESSION NUMBER: 0000885725-24-000068 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 82 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240801 DATE AS OF CHANGE: 20240801 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 241166927 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 10-Q 1 bsx-20240630.htm 10-Q bsx-20240630 0000885725 12/31 2024 Q2 false P1Y P2Y 727 iso4217:USD xbrli:shares xbrli:shares iso4217:USD xbrli:pure iso4217:HKD xbrli:shares utr:Rate iso4217:EUR bsx:derivative_instrument bsx:reportablesegments bsx:business 0000885725 2024-01-01 2024-06-30 0000885725 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0000885725 bsx:SeniorNotedue2027Member 2024-01-01 2024-06-30 0000885725 2024-07-30 0000885725 2024-04-01 2024-06-30 0000885725 2023-04-01 2023-06-30 0000885725 2023-01-01 2023-06-30 0000885725 2024-06-30 0000885725 2023-12-31 0000885725 us-gaap:CommonStockMember 2024-06-30 0000885725 us-gaap:PreferredStockMember 2024-03-31 0000885725 us-gaap:PreferredStockMember 2023-03-31 0000885725 us-gaap:PreferredStockMember 2023-12-31 0000885725 us-gaap:PreferredStockMember 2022-12-31 0000885725 us-gaap:PreferredStockMember 2024-04-01 2024-06-30 0000885725 us-gaap:PreferredStockMember 2023-04-01 2023-06-30 0000885725 us-gaap:PreferredStockMember 2024-01-01 2024-06-30 0000885725 us-gaap:PreferredStockMember 2023-01-01 2023-06-30 0000885725 us-gaap:PreferredStockMember 2024-06-30 0000885725 us-gaap:PreferredStockMember 2023-06-30 0000885725 us-gaap:CommonStockMember 2024-03-31 0000885725 us-gaap:CommonStockMember 2023-03-31 0000885725 2022-12-31 0000885725 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0000885725 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000885725 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0000885725 us-gaap:CommonStockMember 2023-01-01 2023-06-30 0000885725 us-gaap:CommonStockMember 2023-06-30 0000885725 2023-06-30 0000885725 us-gaap:CommonStockMember 2023-12-31 0000885725 us-gaap:CommonStockMember 2022-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2024-03-31 0000885725 us-gaap:TreasuryStockCommonMember 2023-03-31 0000885725 us-gaap:TreasuryStockCommonMember 2023-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2022-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2024-04-01 2024-06-30 0000885725 us-gaap:TreasuryStockCommonMember 2023-04-01 2023-06-30 0000885725 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-06-30 0000885725 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-06-30 0000885725 us-gaap:TreasuryStockCommonMember 2024-06-30 0000885725 us-gaap:TreasuryStockCommonMember 2023-06-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-06-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-06-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000885725 us-gaap:RetainedEarningsMember 2024-03-31 0000885725 us-gaap:RetainedEarningsMember 2023-03-31 0000885725 us-gaap:RetainedEarningsMe